Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Healthcare Biotechnology
Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Liminal BioSciences Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by francois21on Feb 09, 2015 3:58pm
269 Views
Post# 23411776

RE:RE:Moran buying

RE:RE:Moran buyingThe transaction is in US dollar:

Nom de l'initié: Moran, John Edward  
Relations avec l'émetteur: 4 - Administrateur de l'émetteur  
Cessation de la qualité d'initié: Sans objet  
Désignation de titres: Actions ordinaires  
        2225997 2012-03-02 2013-02-19 Propriété directe : 00 - Solde d'ouverture-Déclaration initiale en format SEDI            
   
        2226003 2013-02-05 2013-02-19 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +51,571 0.3800   51,571    
   
        2342214 2013-09-20 2013-09-25 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +7,000 0.6900   58,571    
   
        2346814 2013-10-02 2013-10-04 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +6,400 0.7700   64,971    
   
        2351057 2013-10-11 2013-10-15 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +50,000 0.8900   114,971    
   
        2383033 2013-12-17 2013-12-20 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +7,000 0.7929 $US 121,971    
   
        2383037 2013-12-18 2013-12-20 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +3,000 0.7992 $US 124,971    
   
        2392654 2014-01-06 2014-01-07 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +12,000 0.8600 $US 136,971    
   
        2452950 2014-03-31 2014-04-02 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +39,000 1.0442 $US 175,971    
   
        2522898 2014-08-25 2014-08-26 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +42,000 1.4327 $US 217,971    
   
        2604430 2015-02-06 2015-02-09 Propriété directe : 10 - Acquisition ou aliénation effectuée sur le marché +64,500 1.5100 $US 282,471    
   
        2042370 2012-03-02 2012-03-06 Propriété indirecte :
In Trust 		00 - Solde d'ouverture-Déclaration initiale en format SEDI       50,200    
         

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities